Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
2
days
Focal therapy for localized prostate cancer: not all that glitters is gold
AuthorsAntonio Franco; Jean de la Rosette; Cosimo De Nunzio
Affiliations1. Department of Urology, Sant’Andrea Hospital, Sapienza University, Rome, Italy; 2. Istanbul Medipol University, Istanbul, Türkiye; 3. Bashkir State Medical University, Ufa, Russia
129
days
En-bloc vs lobe-by-lobe laser prostatectomy: where do we stand?
AuthorsMahmoud Laymon; Yahya H. Elmorsy; Ahmed M. Elshal; Ahmed R. El-Nahas; Ahmed M. El-Assmy
Affiliations1. Urology and Nephrology Center, Mansoura University, Mansoura, Egypt
59
days
Methodological and clinical considerations of MRI-based prostate cancer risk calculators
AuthorsWerner T. W. de Riese; Aaron De Souza; Chase Renstrom
Affiliations1. Department of Urology, Texas Tech University Health Sciences Center, Lubbock, USA
190
days
Efficacy and safety of darolutamide plus androgen-deprivation therapy in Black patients with metastatic hormone-sensitive prostate cancer from the phase 3 ARANOTE trial
AuthorsQuoc-Dien Trinh; Daniel J. George; Neal Shore; Egils Vjaters; David Olmos; Andrea Juliana P. de Santana Gomes; Augusto Cesar de Andrade Mota; Natasha Littleton; Shankar Srinivasan; Frank Verholen; Kunhi Parambath Haresh; Fred Saad
Affiliations1. University of Pittsburgh Medical Center, Pittsburgh, USA; 2. Duke University School of Medicine, Duke Cancer Institute, Durham, USA; 3. Carolina Urologic Research Center and AUC Urology Specialists, Myrtle Beach, USA; 4. P. Stradinš Clinical University Hospital, Riga, Latvia; 5. Department of Medical Oncology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12), Madrid, Spain; 6. Liga Norte Riograndense Contra O Cancer, Natal, Brazil; 7. Medical Oncology, Instituto ETICA – Clinica AMO/DASA, Salvador, Brazil; 8. Bayer Ltd, Dublin, Ireland; 9. Bayer Healthcare, Whippany, USA; 10. Bayer Consumer Care AG, Basel, Switzerland; 11. All India Institute of Medical Sciences, New Delhi, India; 12. University of Montreal Hospital Centre, Montreal, Canada
72
days
Missing the full picture: Pathology, anatomy, and operator effects in HoLEP comparisons
AuthorsZuomin Wang; Qinwei Liu; Wangdong Deng
Affiliations1. Urology of Shenzhen Longgang Central Hospital, Shenzhen, China
129
days
Letter: The Hawthorne effect—behavioral changes from research observation—as confounder and mediator in the ERASE trial
AuthorsZuomin Wang; Qinwei Liu; Wangdong Deng
Affiliations1. Urology of Shenzhen Longgang Central Hospital, Shenzhen, China
127
days
Navigating drug–drug interactions with apalutamide
AuthorsBilal A. Siddiqui; Karine Tawagi; Sarah Caulfield; Pankaj Aggarwal; Tanya Dorff
Affiliations1. Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA; 2. Department of Medicine, Division of Hematology and Oncology, University of Illinois Chicago, Chicago, USA; 3. Genitourinary Clinic, Emory Healthcare, Winship Cancer Institute, Atlanta, USA; 4. Johnson & Johnson, Horsham, USA; 5. Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, USA
21
days
Refining risk assessment: bridging statistical innovation and clinical reality
AuthorsKaifei Chen; Jiangfang Feng; Jinjun Chang
Affiliations1. Department of Urology, Jin Cheng People’s Hospital, Jincheng, China; 2. Department of Hematology, The Second People’s Hospital of Jincheng City, Jincheng, China
52
days
Best of 2025 in prostate cancer and prostatic diseases
AuthorsCosimo De Nunzio; Riccardo Lombardo
Affiliations1. Department of Urology, Ospedale Sant’Andrea, Sapienza University of Rome, Rome, Italy
184
days
Radical prostatectomy without prior biopsy: an initial decision-making algorithm based on PSMA PET/mpMRI
AuthorsZhuoran Li; Jin Luo; Qiwei Liu; Yuqi Jia; Zhiqiang Chen; Nanxin Zou; Jinqiao Li; Yujie Dong; Qiming Yang; Chao Wang; Zhuo Jia; Yundong Xuan; Xiaohui Ding; Honghao Xu; Baichuan Liu; Xixi Wang; Haiyi Wang; Yachao Liu; Xu Zhang; Weimin Ci; Shaoxi Niu; Songliang Du; Baojun Wang
Affiliations1. School of Medicine, Nankai University, Tianjin, China; 2. Department of Urology, The Third Medical Center of Chinese PLA General Hospital, Beijing, China; 3. Department of Urology, The PLA Joint Logistic Support Force, 983rd Hospital, Tianjin, China; 4. Graduate School of PLA Medical College, Chinese PLA General Hospital, Beijing, China; 5. Department of Pathology, The First Medical Centre of Chinese PLA General Hospital, Beijing, China; 6. Department of Radiology, The First Medical Centre of Chinese PLA General Hospital, Beijing, China; 7. Department of Nuclear Medicine, The First Medical Centre of Chinese PLA General Hospital, Beijing, China
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days